Who Paid My Doc
LifeVest
Device Electromedical and Electrotherapeutic Apparatus
General payments
$24,414,079
Research payments
$6,203,692
Through program year 2025, $24,414,079 in general payments and $6,203,692 in research payments were reported against LifeVest (Electromedical and Electrotherapeutic Apparatus).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
14 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $3,890,499 | 85,227 |
| 2025 | Research | $250 | 1 |
| 2024 | General | $3,840,843 | 80,252 |
| 2024 | Research | $187,715 | 47 |
| 2023 | General | $4,064,124 | 73,786 |
| 2023 | Research | $401,467 | 254 |
| 2022 | General | $3,704,712 | 58,086 |
| 2022 | Research | $1,362,178 | 240 |
| 2021 | General | $3,357,146 | 56,684 |
| 2021 | Research | $1,674,711 | 258 |
| 2020 | General | $2,256,965 | 33,094 |
| 2020 | Research | $1,077,686 | 277 |
| 2019 | General | $3,299,792 | 48,730 |
| 2019 | Research | $1,499,684 | 206 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 131 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
435,859 general · 1,283 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.